References
- Linh NN, Viney K, Gegia M, et al. World Health Organization treatment outcome definitions for tuberculosis: 2021 update. Eur Respir J. 2021;58(2):2100804. doi:10.1183/13993003.00804-2021
- Mugwagwa T, Abubakar I, White PJ. Using molecular testing and whole-genome sequencing for tuberculosis diagnosis in a low-burden setting: a cost-effectiveness analysis using transmission-dynamic modelling. Thorax. 2021;76(3):281–291. doi:10.1136/thoraxjnl-2019-214004
- Okkels LM, Brock I, Follmann F, et al. PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family. Infect Immun. 2003;71(11):6116–6123. doi:10.1128/IAI.71.11.6116-6123.2003
- Q-h L, Zhang Y, Zhao -M-M, et al. Simultaneous amplification and testing method for Mycobacterium tuberculosis rRNA to differentiate sputum-negative tuberculosis from sarcoidosis. Am J Physiol Lung Cell Mol Physiol. 2019;316(3):L519–L524. doi:10.1152/ajplung.00172.2018
- Fijołek J, Wiatr E, Polubiec-Kownacka M, et al. Pulmonary tuberculosis mimicking lung cancer progression after 10 years of cancer remission. Adv Respir Med. 2018;86(2):92–96. doi:10.5603/ARM.2018.0012
- Honkala AT, Tailor D, Malhotra SV. Guanylate-binding protein 1: an emerging target in inflammation and cancer. Front Immunol. 2019;10:3139. doi:10.3389/fimmu.2019.03139
- Chen G, Yu M, Cao J, et al. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis. Bioengineered. 2021;12(1):5149–5161. doi:10.1080/21655979.2021.1960775
- McCaffrey EF, Donato M, Keren L, et al. The immunoregulatory landscape of human tuberculosis granulomas. Nat Immunol. 2022;23(2):318–329. doi:10.1038/s41590-021-01121-x
- Suthar PP, Bumiya RG, Patel K, Patel AB. Incidental diagnosis of liver tuberculosis in a patient with jaundice. BMJ Case Rep. 2015;2015(mar02 1):bcr2014206866–bcr2014206866. doi:10.1136/bcr-2014-206866
- Park J-I. Primary hepatic tuberculosis mimicking intrahepatic cholangiocarcinoma: report of two cases. Ann Surg Treat Res. 2015;89(2):98–101. doi:10.4174/astr.2015.89.2.98
- Bova C, De Stefano R, Pignataro FS, Ruvio M. Hepatic tuberculosis mimicking cholangiocarcinoma. IDCases. 2023;32:e01776. doi:10.1016/j.idcr.2023.e01776
- Luther VP, Bookstaver PB, Ohl CA. Corticosteroids in the treatment of hepatic tuberculosis: case report and review of the literature. Scand J Infect Dis. 2010;42(4):315–317. doi:10.3109/00365540903490034
- Djaharuddin I, Hatta M, Tabri NA, Muis E, Safriadi S, Primaguna MR. Intestinal tuberculosis: case series of three patients. Respir Med Case Rep. 2020;29:100942. doi:10.1016/j.rmcr.2019.100942